We are live on ! Find out more
ARKG icon

ARK Genomic Revolution ETF
ARKG

284 hedge funds and large institutions have $609M invested in ARK Genomic Revolution ETF in 2024 Q1 according to their latest regulatory filings, with 27 funds opening new positions, 64 increasing their positions, 104 reducing their positions, and 36 closing their positions.

New
Increased
Maintained
Reduced
Closed

5.9% more ownership

Funds ownership: 31.32% → 37.22% (+5.9%)

5% less funds holding

Funds holding: 298 → 284 (-14)

9% less capital invested

Capital invested by funds: $671M → $609M (-$61.7M)

25% less first-time investments, than exits

New positions opened: 27 | Existing positions closed: 36

38% less repeat investments, than reductions

Existing positions increased: 64 | Existing positions reduced: 104

50% less funds holding in top 10

Funds holding in top 10: 2 → 1 (-1)

59% less call options, than puts

Call options by funds: $49.5M | Put options by funds: $121M

Holders
284
Holders Change
-14
Holders Change %
-4.7%
% of All Funds
4.09%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.01%
New
27
Increased
64
Reduced
104
Closed
36
Calls
$49.5M
Puts
$121M
Net Calls
-$71M
Net Calls Change
-$49.1M

Top Buyers

Rank Fund Capital Flow
1
BNP Paribas Financial Markets
BNP Paribas Financial Markets
France
+$35.3M
2
JP Morgan Chase
JP Morgan Chase
New York
+$24M
3
Wells Fargo
Wells Fargo
California
+$15.9M
4
Citadel Advisors
Citadel Advisors
Florida
+$9.24M
5
Citigroup
Citigroup
New York
+$7.42M

Top Sellers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
-$37.4M
2
State of Wisconsin Investment Board
State of Wisconsin Investment Board
Wisconsin
-$9.15M
3
Goldman Sachs
Goldman Sachs
New York
-$8.92M
4
Two Sigma Advisers
Two Sigma Advisers
New York
-$7.29M
5
Two Sigma Investments
Two Sigma Investments
New York
-$6.54M
Name Holding Trade Value Shares
Change 		Change in
Stake
SS
226
Sunbelt Securities
Texas
$5.58K – – –
FFA
227
Frazier Financial Advisors
Ohio
$5.46K – – –
ADL
228
Asset Dedication LLC
California
$5K – – –
DMIC
229
Dixon Mitchell Investment Counsel
British Columbia, Canada
$4.89K +$5.11K +170 New
HI
230
Harbour Investments
Wisconsin
$4.31K – – –
PTC
231
Private Trust Company
Ohio
$4.31K – – –
PA
232
Parallel Advisors
California
$4.31K +$902 +30 +25%
NCM
233
Northwest Capital Management
Oregon
$4.29K – – –
S
234
Sachetta
Massachusetts
$4.04K – – –
BFPW
235
BOK Financial Private Wealth
Colorado
$4.03K – – –
HFS
236
Hantz Financial Services
Michigan
$4K – – –
PP
237
PrairieView Partners
Minnesota
$4K – – –
VWM
238
Venturi Wealth Management
Texas
$4K -$1.23K -41 -23%
AA
239
Ancora Advisors
Ohio
$3.42K -$261K -8,686 -99%
BBPWM
240
Blue Bell Private Wealth Management
Pennsylvania
$3.34K – – –
S
241
Syntrinsic
Colorado
$3.08K – – –
CAL
242
Capital Analysts LLC
Pennsylvania
$3K – – –
CA
243
CoreCap Advisors
Michigan
$2.99K +$3.13K +104 New
VL
244
Vima LLC
Michigan
$2.96K -$571 -19 -16%
HWP
245
Highline Wealth Partners
California
$2.89K – – –
BWL
246
Bogart Wealth LLC
Virginia
$2.88K – – –
CHA
247
Carmichael Hill & Associates
Maryland
$2.88K – – –
HNB
248
Hilltop National Bank
Wyoming
$2.88K +$3.01K +100 New
RFA
249
Register Financial Advisors
Georgia
$2.73K +$2.86K +95 New
TSMHT
250
Thurston Springer Miller Herd & Titak
Indiana
$2.66K +$2.77K +92 New
8 9
10
11 12

ARKG Hedge Fund Activity: Q1 2024 in Review

284 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in ARK Genomic Revolution ETF (ARKG) for Q1 2024, worth a combined $609M — down 9.2% from $671M a quarter earlier.

Sellers outnumbered buyers: 36 funds closed out of ARKG and 27 opened new positions — a net loss of 9 holders — while 104 trimmed existing stakes and 64 added.

The largest buyer was BNP Paribas Financial Markets, adding an estimated $35.3M. The largest seller was Morgan Stanley, cutting an estimated $37.4M.

  • 284 institutional investors held ARK Genomic Revolution ETF (ARKG) as of Q1 2024, down from 298 in Q4 2023.
  • Funds reported $609M of ARK Genomic Revolution ETF stock for Q1 2024, down 9.2% quarter-over-quarter.
  • 27 funds opened new ARK Genomic Revolution ETF positions in Q1 2024 and 36 closed out, a net change of -9 holders.
  • The largest ARK Genomic Revolution ETF buyer in Q1 2024 was BNP Paribas Financial Markets, an estimated $35.3M added.
  • The largest ARK Genomic Revolution ETF seller in Q1 2024 was Morgan Stanley, an estimated $37.4M sold.

Based on aggregated 13F filings for Q1 2024.